Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Venus Medtech (Hangzhou), Inc. Class H ( (HK:2500) ) has issued an announcement.
Venus Medtech (Hangzhou) Inc. has announced the composition of its board of directors and their respective roles within various board committees. This update reflects the company’s commitment to strong corporate governance and strategic leadership, which is crucial for maintaining its competitive position in the medical technology sector.
More about Venus Medtech (Hangzhou), Inc. Class H
Venus Medtech (Hangzhou) Inc. is a joint stock company incorporated in the People’s Republic of China, operating within the medical technology industry. The company focuses on developing and providing innovative medical devices, particularly in the field of heart valve replacement and related cardiovascular solutions.
Average Trading Volume: 3,177,973
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$1.16B
Learn more about 2500 stock on TipRanks’ Stock Analysis page.